Prostate cancer surgery imaging study
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a fluorescent dye that helps surgeons see prostate cancer during surgery. It may help doctors remove cancer more completely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer confirmed by a biopsy.
- You are scheduled to have surgery to remove your prostate.
- You are 18 years or older.
- Your cancer has a Gleason score of 7 or higher, or imaging shows it has spread beyond the prostate.
- Your liver and kidneys are working well enough.
- You and your partner agree to use birth control or not donate sperm for 3 months after the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special PET/MRI scan that may help doctors see if prostate cancer has spread to nearby lymph nodes before surgery. It could help guide treatment decisions for men with high-risk prostate cancer.
This trial tests if a special PET scan using PSMA-1007 can find prostate cancer spread in men who have just been diagnosed with high-risk prostate cancer and plan to have surgery. The scan may help doctors better understand the cancer before removing the prostate and lymph nodes.
This trial tests if a special PET scan (PSMA-PET) plus MRI is better than MRI alone at finding the full extent of high-risk prostate cancer before surgery. It aims to improve surgical planning by checking scan results against the removed prostate tissue.
This trial compares two radioactive drugs (177Lu-PSMA-617 and 225Ac-PSMA-617) given before prostate removal surgery in men with high-risk prostate cancer that has not spread far. The goal is to see which drug is better at shrinking the tumor and reducing the chance of cancer coming back.
This Phase 1 study tests nanoparticles (tiny particles) that are meant to help surgeons better find and remove prostate cancer tissue during surgery. You may be offered standard prostate surgery plus imaging with a study tracer to guide the operation.
This study tests a new imaging agent (68Ga-NYM032) used with PET/CT scans to help doctors better detect prostate cancer before surgery. If you have biopsy-confirmed prostate cancer and are planning to have your prostate removed, this trial may help evaluate whether this new imaging method improves cancer detection.
Hear when a new Prostate Cancer Patients Undergoing Radical Prostatectomy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.